Form 8-K - Current report:
SEC Accession No. 0001558370-25-008870
Filing Date
2025-06-26
Accepted
2025-06-26 08:03:03
Documents
12
Period of Report
2025-06-26
Items
Item 7.01: Regulation FD Disclosure

Document Format Files

Seq Description Document Type Size
1 8-K mgtx-20250626x8k.htm   iXBRL 8-K 37414
  Complete submission text file 0001558370-25-008870.txt   150483

Data Files

Seq Description Document Type Size
2 EX-101.SCH mgtx-20250626.xsd EX-101.SCH 3411
3 EX-101.LAB mgtx-20250626_lab.xml EX-101.LAB 15930
4 EX-101.PRE mgtx-20250626_pre.xml EX-101.PRE 10055
14 EXTRACTED XBRL INSTANCE DOCUMENT mgtx-20250626x8k_htm.xml XML 4863
Mailing Address 450 EAST 29TH STREET 14TH FLOOR NEW YORK NY 10016
Business Address 450 EAST 29TH STREET 14TH FLOOR NEW YORK NY 10016 646-860-7985
MeiraGTx Holdings plc (Filer) CIK: 0001735438 (see all company filings)

EIN.: 981448305 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38520 | Film No.: 251075095
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)